Background: Equivocal atypia in respiratory cytology can be a diagnostic challenge. In such cases fluorescence in situ hybridization (FISH) may be used for the analysis of chromosomal aberrations and often allows a reliable distinction of benign and malignant cells.
Methods: An online picture gallery of 30 respiratory cytologic preparations comprising 23 specimens with equivocal cytology as well as 5 positive and 2 negative controls was prepared (www.unibas.ch/patho/lungenzyto/loesung). The final diagnoses were confirmed by clinical follow-up or biopsy or both. Each of the illustrated cell groups was analyzed by multitarget FISH after PAP image capturing and automatic relocalization.
Results: The online questionnaire was completed by 137 cytomorphologists from all continents. The control cases were assessed accurately to a significantly higher percentage than the equivocal cases. In equivocal cases participants more often made false-positive than false-negative diagnoses. In 2 patients with benign conditions (tuberculosis and pulmonary capillaritis) the rate of false-positive answers was remarkably high (31.4% and 62.8% respectively). The result of the 20 best-performing participants for the 5 cases with the highest percentage of inaccurate answers was not better than if they had chosen their answer by chance.
Conclusions: These data illustrate that single cells or cell clusters of a subgroup of equivocal lung cytology are a diagnostic challenge even for highly experienced morphologists. Internet-based tests are able to reveal limitations of cytomorphology.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cncr.22286 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
General Practice chest x-ray rate is associated with earlier lung cancer diagnosis and reduced all-cause mortality: a retrospective observational study.
Br J Gen Pract
December 2024
University College London, London, United Kingdom.
Background: Evidence on whether general practice rates of investigation in symptomatic patients using chest x-ray (CXR) affects outcomes is equivocal.
Aim: Determine if there is an association between rates of general practice (GP) requested CXR and lung cancer outcomes.
Design And Setting: Retrospective observational study (England) Methods: Cancer registry data for patients diagnosed with lung cancer 2014-2018 was linked to data on GP CXRs 2013-2017.
Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio.
In Vivo
December 2024
First Department of Internal Medicine, Toyama University Hospital, Toyama, Japan.
Background/aim: Chemoimmunotherapy has improved overall survival in patients with extensive small-cell lung cancer (SCLC). However, the backgrounds of patients enrolled in clinical trials tend to differ from those of patients treated in clinical practice, and the effectiveness of chemoimmunotherapy may be unclear in some populations, including patients with poor performance status. This study aimed to evaluate the effectiveness of chemoimmunotherapy for SCLC patients in clinical practice while focusing on several subgroups.
View Article and Find Full Text PDFDiagnostic yield of a novel tracer 68Ga-citrate in sarcoidosis patients.
Sarcoidosis Vasc Diffuse Lung Dis
December 2024
Professor, M.D, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul-Cerrahpasa University.
Background: Sarcoidosis is a granulomatous disease of unknown origin. Conventional laboratory and imaging modalities may lead to equivocal conclusions for sarcoidosis diagnosis. 68Ga-citrate PET/CT has been utilized in the diagnosis of inflammatory and infectious diseases due to its beter performance.
View Article and Find Full Text PDFPrognosis of Equivocal Interstitial Lung Abnormalities in a Health Check-up Population.
Ann Am Thorac Soc
November 2024
St Luke's International Hospital, Division of Pulmonary Medicine, Tokyo, Japan.
Rationale: Equivocal interstitial lung abnormality (ILA) involves less than 5% of any lung zone or presents unilaterally without satisfying the diagnostic criteria for ILA; however, the prevalence and prognosis of equivocal ILA are unknown.
Objectives: To investigate the prevalence and long-term prognosis of equivocal ILA.
Methods: This retrospective cohort study included individuals who underwent chest CT as part of a health check-up program in 2010 at St.
Meta-Analysis of Interobserver Agreement in Assessment of Interstitial Lung Disease Using High-Resolution CT.
Radiology
October 2024
From the Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield Royal Hallamshire Hospital, Glossop Rd, Sheffield, United Kingdom, S10 2JF (L.D., S.A., A.M., E.C., A.J.S., K.D.); Department of Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom (S.A., A.M., M.S., S.M., M.K., O.E., S.R., C.J., A.J.S., K.D.); NIHR Sheffield Biomedical Research Centre, Sheffield, United Kingdom (S.A., A.J.S., K.D.); Chesterfield Royal Hospital, Chesterfield Royal NHS Foundation Trust, Chesterfield, United Kingdom (M.G.); College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia (H.S.); and Department of Radiology, Papworth Hospital, Cambridge, United Kingdom (N.J.S.).
Background High-resolution CT (HRCT) is central to the assessment of interstitial lung disease (ILD), and accurate classification of disease has important implications for patients. Evaluation of imaging features can be challenging, even for experienced thoracic radiologists. Previous work has provided equivocal evidence on the interpretation of HRCT features at ILD-related imaging.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!